Trazadone 150mg

Company
Teva Pharmaceutical

Approval Status
Approved May 1997

Treatment for
depression

Areas
Diabetes / Endocrinology , Psychiatry / Psychiatric

Trazadone 150mg tablets have been approved to manufacture and market as a treatment for depression. Teva previously received approval for 50mg and 100mg dosage strengths. Trazadone is the generic equivalent of Bristol Meyers Squibb’s Desyrel 7.

Trazadone_150mg Drug Information

The Trazadone_150mg drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top